Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 Product No. of Patients Collaborator Design Data Read Out Next Steps TRPՓ8802 20 Open label with psychotherapy Interim data expected in 2022 Submit IND in 4Q 2021 and begin enrollment in 1Q 2022 TRPՓ8802 50 TBA in Q4 2021 Placebo controlled with psychotherapy Interim data expected in 2022 IND has been submitted; begin enrollment in 4Q 2021 TRPՓ8802 10 TBA in Q4 2021 Open label with psychotherapy Interim data expected in 2022 Submit IND in 1Q 2022 and begin enrollment in 2Q 2022 A CLOSER LOOK: PHASE 2A CLINICAL TRIAL FOR CRPS 20 Fibromyalgia Phantom Limb Pain CRPS

RkJQdWJsaXNoZXIy NDMyMDk=